In patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis in sustained remission, reinfusion with rituximab after B cell repopulation resulted in fewer clinical relapses than did reinfusion following serological ANCA flare.

中文翻译：

---

B 细胞引导利妥昔单抗用于 AAV 缓解

在持续缓解的抗中性粒细胞胞浆抗体 (ANCA) 相关血管炎患者中，B 细胞再增殖后回输利妥昔单抗导致的临床复发率低于血清学 ANCA 发作后回输的临床复发率。